These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 24814553)

  • 1. Safety and reactogenicity of BCG revaccination with isoniazid pretreatment in TST positive adults.
    Hatherill M; Geldenhuys H; Pienaar B; Suliman S; Chheng P; Debanne SM; Hoft DF; Boom WH; Hanekom WA; Johnson JL
    Vaccine; 2014 Jun; 32(31):3982-8. PubMed ID: 24814553
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses.
    Suliman S; Geldenhuys H; Johnson JL; Hughes JE; Smit E; Murphy M; Toefy A; Lerumo L; Hopley C; Pienaar B; Chheng P; Nemes E; Hoft DF; Hanekom WA; Boom WH; Hatherill M; Scriba TJ
    J Immunol; 2016 Aug; 197(4):1100-1110. PubMed ID: 27412415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Making wider use of the world's most widely used vaccine: Bacille Calmette-Guerin revaccination reconsidered.
    Dye C
    J R Soc Interface; 2013 Oct; 10(87):20130365. PubMed ID: 23904584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A CD4+ TNF+ monofunctional memory T-cell response to BCG vaccination is associated with Mycobacterium tuberculosis infection in infants exposed to HIV.
    Warr AJ; Anterasian C; Shah JA; De Rosa SC; Nguyen FK; Maleche-Obimbo E; Cranmer LM; Matemo D; Mecha J; Kinuthia J; LaCourse SM; John-Stewart GC; Hawn TR
    EBioMedicine; 2022 Jun; 80():104023. PubMed ID: 35533496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contact Investigations With a Single Tuberculin Skin Test on Infants Exposed to Tuberculosis in a Postpartum Care Center During the Neonatal Period.
    Choi SH; Oh CE; Lee J; Cho YY; Kwon Y; Kim J; Lee H; Park SE
    J Korean Med Sci; 2023 Sep; 38(38):e301. PubMed ID: 37750372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of tuberculin skin test for isoniazid prophylaxis in BCG vaccinated children who are using anti-TNF agents for rheumatologic diseases.
    Kilinc AA; Onal P; Oztosun B; Yildiz M; Adrovic A; Sahin S; Barut K; Cokugras H; Kasapcopur O
    Pediatr Pulmonol; 2020 Oct; 55(10):2689-2696. PubMed ID: 32776324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized clinical trial in adults and newborns in South Africa to compare the safety and immunogenicity of bacille Calmette-Guérin (BCG) vaccine administration via a disposable-syringe jet injector to conventional technique with needle and syringe.
    Geldenhuys HD; Mearns H; Foster J; Saxon E; Kagina B; Saganic L; Jarrahian C; Tameris MD; Dintwe OB; Van Rooyen M; Luabeya KK; Hussey G; Scriba TJ; Hatherill M; Zehrung D
    Vaccine; 2015 Sep; 33(37):4719-26. PubMed ID: 25862299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distinct effector memory CD4+ T cell signatures in latent Mycobacterium tuberculosis infection, BCG vaccination and clinically resolved tuberculosis.
    Adekambi T; Ibegbu CC; Kalokhe AS; Yu T; Ray SM; Rengarajan J
    PLoS One; 2012; 7(4):e36046. PubMed ID: 22545156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of QuantiFERON-TB gold in-tube test with tuberculin skin test in children who had no contact with active tuberculosis case.
    Metin Timur Ö; Tanir G; Öz FN; Bayhan Gİ; Aydin Teke T; Tuygun N
    Tuberk Toraks; 2014; 62(2):116-21. PubMed ID: 25038380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of QuantiFERON-TB Gold In-Tube test and Tuberculin Skin Test for diagnosis of latent tuberculosis infection in BCG vaccinated health care workers.
    Babayigit C; Ozer B; Ozer C; Inandi T; Duran N; Gocmen O
    Med Sci Monit; 2014 Mar; 20():521-9. PubMed ID: 24681806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic review protocol on Bacillus Calmette-Guerin (BCG) revaccination and protection against tuberculosis.
    Mahasha PW; Ndwandwe DE; Mavundza EJ; Shey M; Wiysonge CS
    BMJ Open; 2019 Oct; 9(10):e027033. PubMed ID: 31619416
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of Treatment Indications, Tuberculin Skin Test, and Bacillus Calmette-Guerin Vaccination Scars in the Cases of Latent Tuberculosis Infection Treatment.
    Çakar B
    Turk Thorac J; 2018 Jan; 19(1):7-12. PubMed ID: 29404180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnosis of latent tuberculosis infection in healthy young adults in a country with high tuberculosis burden and BCG vaccination at birth.
    Dagnew AF; Hussein J; Abebe M; Zewdie M; Mihret A; Bedru A; Chanyalew M; Yamuah L; Medhin G; Bang P; Doherty TM; Hailu A; Aseffa A
    BMC Res Notes; 2012 Aug; 5():415. PubMed ID: 22870897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of neonatal bacille Calmette-Guérin on the tuberculin skin test reaction in the first 2 years of life.
    Kurtz T; Feil AC; Nascimento LS; de Oliveira Abreu P; Scotta MC; Pinto LA
    Int J Tuberc Lung Dis; 2019 Mar; 23(3):344-348. PubMed ID: 30871666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of BCG vaccination and risk factors for latent tuberculosis infection among college freshmen in China.
    Huang W; Fang Z; Luo S; Lin S; Xu L; Yan B; Yang Y; Liu X; Xia L; Fan X; Lu S
    Int J Infect Dis; 2022 Sep; 122():321-326.2. PubMed ID: 35700876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. To TST or not to TST: is tuberculin skin testing necessary before BCG immunisation in children?
    Ritz N; Tebruegge M; Camacho-Badilla K; Haeusler GM; Connell TG; Curtis N
    Vaccine; 2012 Feb; 30(8):1434-6. PubMed ID: 22155145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of Latent TB and Effectiveness of BCG Vaccination Against Latent Tuberculosis: An Observational Study.
    Trollfors B; Sigurdsson V; Dahlgren-Aronsson A
    Int J Infect Dis; 2021 Aug; 109():279-282. PubMed ID: 34174429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tuberculin skin test is unreliable in school children BCG-vaccinated in infancy and at low risk of tuberculosis infection.
    Jacobs S; Warman A; Richardson R; Yacoub W; Lau A; Whittaker D; Cockburn S; Verma G; Boffa J; Tyrrell G; Kunimoto D; Manfreda J; Langlois-Klassen D; Long R
    Pediatr Infect Dis J; 2011 Sep; 30(9):754-8. PubMed ID: 21487326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and efficacy of the C-Tb skin test to diagnose Mycobacterium tuberculosis infection, compared with an interferon γ release assay and the tuberculin skin test: a phase 3, double-blind, randomised, controlled trial.
    Ruhwald M; Aggerbeck H; Gallardo RV; Hoff ST; Villate JI; Borregaard B; Martinez JA; Kromann I; Penas A; Anibarro LL; de Souza-Galvão ML; Sánchez F; Rodrigo-Pendás JÁ; Noguera-Julian A; Martínez-Lacasa X; Tuñez MV; Fernández VL; Millet JP; Moreno A; Cobos N; Miró JM; Roldan L; Orcau A; Andersen P; Caylá JA;
    Lancet Respir Med; 2017 Apr; 5(4):259-268. PubMed ID: 28159608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.